1515 Overzicht aandelen
China Resources Medical Holdings Company Limited, een investeringsmaatschappij, biedt algemene gezondheidszorg, ziekenhuismanagement en andere ziekenhuisgerelateerde diensten in de Volksrepubliek China.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 4/6 |
| Toekomstige groei | 3/6 |
| Prestaties in het verleden | 0/6 |
| Financiële gezondheid | 4/6 |
| Dividenden | 3/6 |
China Resources Medical Holdings Company Limited Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | HK$4.11 |
| 52 Week Hoogtepunt | HK$5.11 |
| 52 Week Laag | HK$3.06 |
| Bèta | 0.71 |
| 11 maand verandering | -14.02% |
| 3 maanden verandering | 25.69% |
| 1 Jaar Verandering | -17.96% |
| 33 jaar verandering | -19.25% |
| 5 jaar verandering | -12.92% |
| Verandering sinds IPO | -58.90% |
Recent nieuws en updates
Recent updates
Market Participants Recognise China Resources Medical Holdings Company Limited's (HKG:1515) Earnings Pushing Shares 34% Higher
Oct 02
We Think You Can Look Beyond China Resources Medical Holdings' (HKG:1515) Lackluster Earnings
May 06China Resources Medical Holdings (HKG:1515) Has A Pretty Healthy Balance Sheet
Apr 26Shareholders Should Be Pleased With China Resources Medical Holdings Company Limited's (HKG:1515) Price
Mar 09Is China Resources Medical Holdings (HKG:1515) Using Too Much Debt?
Nov 29China Resources Medical Holdings' (HKG:1515) Returns Have Hit A Wall
Oct 19Analyst Forecasts For China Resources Medical Holdings Company Limited (HKG:1515) Are Surging Higher
Aug 30Should You Think About Buying China Resources Medical Holdings Company Limited (HKG:1515) Now?
Aug 26China Resources Medical Holdings (HKG:1515) Has A Pretty Healthy Balance Sheet
Jun 30China Resources Medical Holdings (HKG:1515) Will Be Hoping To Turn Its Returns On Capital Around
May 12Analysts Just Published A Bright New Outlook For China Resources Medical Holdings Company Limited's (HKG:1515)
Apr 03Is It Too Late To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?
Feb 21China Resources Medical Holdings (HKG:1515) May Have Issues Allocating Its Capital
Jan 10We Think China Resources Medical Holdings (HKG:1515) Can Manage Its Debt With Ease
Nov 30Is China Resources Medical Holdings Company Limited (HKG:1515) Trading At A 23% Discount?
Oct 18China Resources Medical Holdings (HKG:1515) Will Want To Turn Around Its Return Trends
Sep 21Are Investors Undervaluing China Resources Medical Holdings Company Limited (HKG:1515) By 47%?
Jul 13Is It Time To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?
Jun 24China Resources Medical Holdings (HKG:1515) Is Increasing Its Dividend To HK$0.12
Jun 03China Resources Medical Holdings (HKG:1515) Will Pay A Larger Dividend Than Last Year At HK$0.12
Apr 27We Think China Resources Medical Holdings (HKG:1515) Can Manage Its Debt With Ease
Apr 22Growth Investors: Industry Analysts Just Upgraded Their China Resources Medical Holdings Company Limited (HKG:1515) Revenue Forecasts By 45%
Mar 30Is Now An Opportune Moment To Examine China Resources Medical Holdings Company Limited (HKG:1515)?
Jan 27China Resources Medical Holdings Company Limited (HKG:1515) Shares Could Be 37% Below Their Intrinsic Value Estimate
Jan 03China Resources Medical Holdings (HKG:1515) Will Be Hoping To Turn Its Returns On Capital Around
Nov 19Is It Too Late To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?
Oct 26An Intrinsic Calculation For China Resources Medical Holdings Company Limited (HKG:1515) Suggests It's 44% Undervalued
Sep 20Here's Why China Resources Medical Holdings (HKG:1515) Can Manage Its Debt Responsibly
Sep 06China Resources Medical Holdings (HKG:1515) Might Be Having Difficulty Using Its Capital Effectively
Aug 17Broker Revenue Forecasts For China Resources Medical Holdings Company Limited (HKG:1515) Are Surging Higher
Jun 21China Resources Medical Holdings Company Limited (HKG:1515) Shares Could Be 34% Below Their Intrinsic Value Estimate
Jun 09Investors Can Find Comfort In China Resources Medical Holdings' (HKG:1515) Earnings Quality
May 03China Resources Medical Holdings Company Limited (HKG:1515) Is Yielding 1.4% - But Is It A Buy?
Apr 22We Think China Resources Medical Holdings (HKG:1515) Can Stay On Top Of Its Debt
Mar 27Should You Be Impressed By China Resources Medical Holdings' (HKG:1515) Returns on Capital?
Mar 12Rendement voor aandeelhouders
| 1515 | HK Healthcare | HK Markt | |
|---|---|---|---|
| 7D | 5.4% | -1.5% | -1.0% |
| 1Y | -18.0% | -23.5% | 15.0% |
Rendement versus industrie: 1515 exceeded the Hong Kong Healthcare industry which returned -23.5% over the past year.
Rendement versus markt: 1515 underperformed the Hong Kong Market which returned 15% over the past year.
Prijsvolatiliteit
| 1515 volatility | |
|---|---|
| 1515 Average Weekly Movement | 8.4% |
| Healthcare Industry Average Movement | 8.4% |
| Market Average Movement | 9.0% |
| 10% most volatile stocks in HK Market | 19.0% |
| 10% least volatile stocks in HK Market | 4.3% |
Stabiele aandelenkoers: 1515 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatiliteit in de loop van de tijd: 1515's weekly volatility (8%) has been stable over the past year.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 2007 | 19,640 | Hai Yu | www.crmedical.hk |
China Resources Medical Holdings Company Limited, een investeringsmaatschappij, biedt algemene gezondheidszorg, ziekenhuisbeheer en andere ziekenhuisgerelateerde diensten in de Volksrepubliek China. Het bedrijf is actief in drie segmenten: Ziekenhuizen in eigen beheer, Invest-Operate-Transfer (IOT)/Operate-Transfer-ziekenhuizen en andere. Het bedrijf beheert en exploiteert ook ziekenhuizen en klinieken van derden onder het IOT-model.
China Resources Medical Holdings Company Limited Samenvatting
| 1515 fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | HK$5.33b |
| Inkomsten(TTM) | HK$322.17m |
| Inkomsten(TTM) | HK$10.93b |
16.5x
Koers/Winstverhouding0.5x
P/S-verhoudingIs 1515 overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| 1515 resultatenrekening (TTM) | |
|---|---|
| Inkomsten | CN¥9.97b |
| Kosten van inkomsten | CN¥8.12b |
| Brutowinst | CN¥1.85b |
| Overige uitgaven | CN¥1.56b |
| Inkomsten | CN¥293.95m |
Laatst gerapporteerde inkomsten
Jun 30, 2024
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | 0.23 |
| Brutomarge | 18.58% |
| Nettowinstmarge | 2.95% |
| Schuld/Eigen Vermogen Verhouding | 27.1% |
Hoe presteerde 1515 op de lange termijn?
Bekijk historische prestaties en vergelijking